Literature DB >> 17724182

Retinopathy in persons without diabetes: the Los Angeles Latino Eye Study.

Jennifer R Chao1, Mei-Ying Lai, Stanley P Azen, Ronald Klein, Rohit Varma.   

Abstract

PURPOSE: To assess the prevalence of retinopathy and its relationship to sociodemographic and clinical characteristics in a population-based cohort of adult Latinos without diabetes mellitus.
METHODS: This was a population-based, cross-sectional study comprising 6357 Latinos, 40 years of age and older, from six census tracts in La Puente, Los Angeles, California. An interviewer-administered questionnaire assessed sociodemographic factors and medical history. Color fundus photographs were taken and graded in a masked manner according to a modified Airlie House Classification Grading System. Participants underwent a physical examination that included height, weight, blood pressure, random serum glucose, and glycosylated hemoglobin measurements. Univariate and multivariate logistic regression analyses were used to assess associations between sociodemographic and clinical characteristics and retinopathy in persons without diabetes.
RESULTS: The prevalence of retinopathy among individuals without diabetes in the Los Angeles Latino Eye Study (LALES) population was 6.6% (95% confidence interval 5.9%-7.4%). Stepwise logistic regression indicated that stage II hypertension (World Health Organization 2003 Guidelines), male gender, current smoking status, and obesity (body mass index >or= 30 kg/m(2)) were associated with retinopathy (odds ratio = 4.3, 1.6, 1.4, and 1.3, respectively). No statistically significant associations with retinopathy were present for Native American ancestry; country of origin; health insurance status; history of cardiovascular disease; or history of aspirin, oral contraceptive, or hormone replacement therapy.
CONCLUSIONS: The data suggest that the prevalence of retinopathy in nondiabetic individuals among Latinos of primarily Mexican ancestry is significant. Independent risk indicators for retinopathy in the study population are hypertension, male gender, current smoking status, and obesity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17724182     DOI: 10.1167/iovs.07-0206

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes?

Authors:  C Sabanayagam; G Liew; E S Tai; A Shankar; S C Lim; T Subramaniam; T Y Wong
Journal:  Diabetologia       Date:  2009-04-22       Impact factor: 10.122

2.  Prevalence and risk factors of diabetic retinopathy in Chongqing pre-diabetes patients.

Authors:  X Chen; Y Zhao; Z Zhou; X Zhang; Q Li; L Bai; M Zhang
Journal:  Eye (Lond)       Date:  2012-03-23       Impact factor: 3.775

3.  Retinopathy in non diabetics, diabetic retinopathy and oxidative stress: a new phenotype in Central Africa?

Authors:  Benjamin Longo-Mbenza; Moise Mvitu Muaka; Wayiza Masamba; Lucien Muizila Kini; Igor Longo Phemba; Dalida Kibokela Ndembe; Doris Tulomba Mona
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

4.  Diabetic Retinopathy Environment-Wide Association Study (EWAS) in NHANES 2005-2008.

Authors:  Kevin Blighe; Sarega Gurudas; Ying Lee; Sobha Sivaprasad
Journal:  J Clin Med       Date:  2020-11-12       Impact factor: 4.241

5.  Retinopathy and cognitive impairment in adults with CKD.

Authors:  Kristine Yaffe; Lynn Ackerson; Tina D Hoang; Alan S Go; Maureen G Maguire; Gui-Shuang Ying; Ebenezer Daniel; Lydia A Bazzano; Martha Coleman; Debbie L Cohen; John W Kusek; Akinlolu Ojo; Stephen Seliger; Dawei Xie; Juan E Grunwald
Journal:  Am J Kidney Dis       Date:  2012-12-01       Impact factor: 8.860

Review 6.  Hypertensive eye disease.

Authors:  Carol Y Cheung; Valérie Biousse; Pearse A Keane; Ernesto L Schiffrin; Tien Y Wong
Journal:  Nat Rev Dis Primers       Date:  2022-03-10       Impact factor: 52.329

7.  Prevalence of retinopathy and its risk factors in a Japanese population.

Authors:  Sayaka Fukushima; Tomoko Nakagami; Chikako Suto; Akira Hirose; Yasuko Uchigata
Journal:  J Diabetes Investig       Date:  2013-02-13       Impact factor: 4.232

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.